Sign inGet started

VENBIO GLOBAL STRATEGIC GP III, LTD

Insider CIK 1869300 · ARTV 10% owner · RYZB 10% owner · VTYX 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARTV Artiva Biotherapeutics, In C Conversion deriv2024-07-222024-07-22214,692— $00SEC↗
ARTV Artiva Biotherapeutics, In C Conversion deriv2024-07-222024-07-22843,592— $00SEC↗
ARTV Artiva Biotherapeutics, In C Conversion2024-07-222024-07-22214,692— $01,058,284SEC↗
ARTV Artiva Biotherapeutics, In P Buy2024-07-222024-07-22416,666$12.00 $5.00M1,936,637SEC↗
ARTV Artiva Biotherapeutics, In J Other2024-07-222024-07-22461,687— $01,519,971SEC↗
ARTV Artiva Biotherapeutics, In C Conversion2024-07-222024-07-22843,592— $0843,592SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-21216,127— $00SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-211,123,862— $00SEC↗
RYZB RayzeBio, Inc. C Conversion deriv2023-09-192023-09-213,786,957— $00SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-21247,343— $05,158,162SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-211,123,862— $04,910,819SEC↗
RYZB RayzeBio, Inc. C Conversion2023-09-192023-09-213,786,957— $03,786,957SEC↗
VTYX Ventyx Biosciences, Inc. A Award deriv2022-06-092022-06-1013,301— $013,301SEC↗
VTYX Ventyx Biosciences, Inc. A Award deriv2022-06-092022-06-1013,301— $013,301SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion deriv2021-10-252021-10-253,289,742— $00SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion deriv2021-10-252021-10-25395,027— $00SEC↗
VTYX Ventyx Biosciences, Inc. C Conversion2021-10-252021-10-253,684,769— $03,684,769SEC↗
VTYX Ventyx Biosciences, Inc. P Buy2021-10-252021-10-25312,500$16.00 $5.00M3,997,269SEC↗